The enrichment of this pathway in our high-risk group suggests that IL-17-mediated signaling may be associated with poor prognosis in patients with cervical cancer, possibly through the recruitment of immunosuppressive cells and the promotion of an immunosuppressive TME (Figures 5A,B). The gene discussed is IL17A; the disease is cervical carcinoma.